Athabasca Oil Corporation (ATH.TO)
CAD 4.8
(-3.61%)
CAD 4.8
(-3.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 305.52 Million | 315.61 Million | 194.25 Million | -22.91 Million | 92.63 Million | 83.84 Million |
| Net Income | -51.22 Million | 572.27 Million | 457.6 Million | -657.52 Million | 246.86 Million | -569.65 Million |
| Depreciation & Amortization | 118.57 Million | 119.57 Million | 112.64 Million | 125.67 Million | 144.45 Million | 173.31 Million |
| Deferred income taxes | 14.08 Million | -413.28 Million | -112.64 Million | -125.67 Million | -144.45 Million | - |
| Stock-based compensation | 54.22 Million | 27.35 Million | 17.32 Million | 3.28 Million | 6.75 Million | 8.56 Million |
| Change in working capital | -525 Thousand | 8.97 Million | 11.87 Million | 11.67 Million | -58.45 Million | 91.21 Million |
| Other non-cash items | 221.05 Million | 21.64 Million | -276.14 Million | 619.66 Million | -102.53 Million | 553.72 Million |
| Investing Cash Flow | 20.56 Million | -145.99 Million | 22.69 Million | -60.99 Million | 90.1 Million | -173.08 Million |
| Investments in PPE | -139.83 Million | -147.44 Million | -92.14 Million | -111.64 Million | -199.14 Million | -276.32 Million |
| Acquisitions | 148.43 Million | 440 Thousand | 20.23 Million | 70.28 Million | 263.28 Million | - |
| Investment purchases | - | - | -112.21 Million | -27.93 Million | -263.73 Million | - |
| Sales/Maturities of investments | - | - | 91.98 Million | -42.35 Million | 447 Thousand | 2.35 Million |
| Other Investing Activities | 11.96 Million | 1.01 Million | 114.83 Million | 50.65 Million | 289.24 Million | 103.24 Million |
| Financing Cash Flow | -170.73 Million | -204.94 Million | -159.19 Million | -2.57 Million | -2.24 Million | -185 Thousand |
| Debt repayment | -26.24 Million | -244.74 Million | -558.92 Million | -2.59 Million | -2.34 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -158.58 Million | - | - | - | - | - |
| Common Stock Issuance | 14.13 Million | 39.79 Million | 36 Thousand | 16 Thousand | 103 Thousand | 165 Thousand |
| Other Financing Activities | 2.57 Million | -204.94 Million | 399.69 Million | -2.57 Million | -2.24 Million | -185 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -525 Thousand | 8.97 Million | 11.87 Million | 11.67 Million | -58.45 Million | 91.21 Million |
| Cash at beginning of period | 197.52 Million | 223.05 Million | 165.2 Million | 254.38 Million | 73.89 Million | 163.32 Million |
| Cash at end of period | 343.3 Million | 197.52 Million | 223.05 Million | 165.2 Million | 254.38 Million | 73.89 Million |
| Capital Expenditure | -139.83 Million | -147.44 Million | -92.14 Million | -111.64 Million | -199.14 Million | -276.32 Million |
| Effect of forex changes on cash | -9.57 Million | 9.79 Million | 104 Thousand | -2.71 Million | - | - |
| Net cash flow / Change in cash | 145.78 Million | -25.53 Million | 57.85 Million | -89.18 Million | 180.49 Million | -89.42 Million |
| Free Cash Flow | 165.69 Million | 168.16 Million | 102.11 Million | -134.55 Million | -106.5 Million | -192.48 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 68.72 Million | 96.07 Million | 38.6 Million | 27.5 Million | -51.22 Million | -79.21 Million |
| Depreciation & Amortization | 33.59 Million | 31.57 Million | 25.65 Million | 26.38 Million | 118.57 Million | 230.19 Million |
| Deferred income taxes | 19.57 Million | 30.03 Million | 13.04 Million | 28.3 Million | 14.08 Million | -16.5 Million |
| Stock-based compensation | - | 1.54 Million | 14.15 Million | 1.76 Million | 54.22 Million | 17.23 Million |
| Change in working capital | 23.6 Million | -30.76 Million | -9.53 Million | 21.97 Million | -525 Thousand | -5.89 Million |
| Other non-cash items | 41.65 Million | 71.3 Million | 60.17 Million | -2.7 Million | 221.05 Million | 6.18 Million |
| Investing Cash Flow | -39.73 Million | -63.54 Million | -63.98 Million | -30.31 Million | 20.56 Million | 114.11 Million |
| Investments in PPE | -50.12 Million | -48.45 Million | -76.01 Million | -38.75 Million | -139.83 Million | -33.28 Million |
| Acquisitions | - | -321 Thousand | -148 Thousand | -1.42 Million | 148.43 Million | 149.86 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 10.9 Million | -14.77 Million | 12.17 Million | 9.86 Million | 11.96 Million | -2.46 Million |
| Financing Cash Flow | -116.03 Million | -77.26 Million | -56.35 Million | -59.2 Million | -170.73 Million | -46.07 Million |
| Debt repayment | -32.58 Million | -480 Thousand | -469 Thousand | -459 Thousand | -26.24 Million | -7.67 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -85.43 Million | -77.98 Million | -74.08 Million | -70.41 Million | -158.58 Million | -41.24 Million |
| Common Stock Issuance | 156 Thousand | 10 Thousand | 18.08 Million | 9.09 Million | 14.13 Million | 2.84 Million |
| Other Financing Activities | 1.83 Million | 1.18 Million | 111 Thousand | 2.57 Million | 2.57 Million | 2.84 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 23.6 Million | -30.76 Million | -9.53 Million | 21.97 Million | -525 Thousand | -5.89 Million |
| Cash at beginning of period | 303.36 Million | 306.5 Million | 343.3 Million | 337.12 Million | 197.52 Million | 132.49 Million |
| Cash at end of period | 334.85 Million | 303.36 Million | 306.5 Million | 343.3 Million | 343.3 Million | 337.12 Million |
| Capital Expenditure | -50.12 Million | -48.45 Million | -76.01 Million | -38.75 Million | -139.83 Million | -33.28 Million |
| Effect of forex changes on cash | - | 2.58 Million | 6.89 Million | -7.49 Million | -9.57 Million | 1.72 Million |
| Net cash flow / Change in cash | 31.49 Million | -3.14 Million | -36.8 Million | 6.18 Million | 145.78 Million | 204.63 Million |
| Free Cash Flow | 137.01 Million | 86.63 Million | 627 Thousand | 64.44 Million | 165.69 Million | 101.59 Million |
8160
3539
GAGAN
EXCELINDUS
AARTIPHARM
ALB